SCHEMBL14411874

SCHEMBL14411874

CCOC(=O)C=C1CN(B(C)O)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 1/20 0.41
▸ MAPK1 P28482 3/20 0.38
▸ HPGD P15428 3/20 0.37
▸ HSD17B10 Q99714 3/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ RECQL P46063 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ HCAR2 Q8TDS4 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA7 P43166 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ CA14 Q9ULX7 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CTDSP1 Q9GZU7 2/20 0.34
▸ LMNA P02545 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25678369 0.80 ESR2 (0.44) ESR2MAPK1HPGDHSD17B10KDM4E
SCHEMBL2674926 0.77 ESR2 (0.42) ESR2MAPK1HPGDHSD17B10KDM4E
SCHEMBL2502784 0.75 — —
SCHEMBL19095523 0.73 ESR2 (0.44) ESR2MAPK1HPGDHSD17B10KDM4E
SCHEMBL17298097 0.73 ESR2 (0.44) ESR2MAPK1HPGDHSD17B10KDM4E
SCHEMBL1668850 0.72 ESR2 (0.54) ESR2MAPK1HPGDHSD17B10KDM4E
SCHEMBL905258 0.72 ESR2 (0.54) ESR2MAPK1HPGDHSD17B10KDM4E
SCHEMBL2676434 0.71 ADORA1 (0.42) ESR2MAPK1RECQLALDH1A1NPSR1
SCHEMBL25313837 0.71 ESR2 (0.53) ESR2MAPK1HPGDHSD17B10KDM4E
SCHEMBL19212169 0.71 ESR2 (0.45) ESR2MAPK1HPGDHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070225269-A1 Use of (3-(1-(3-Phenyl-Propenyl)-Piperidin-4-Yl)-2,3-Dihydro-Indol-1-Yl)-(Pyridin-4-Yl)-Methanonone Derivatives and Related Compounds as Insecticides SYNGENTA CROP PROTECTION, INC. 2007-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225269-A1 Use of (3-(1-(3-Phenyl-Propenyl)-Piperidin-4-Yl)-2,3-Dihydro-Indol-1-Yl)-(Pyridin-4-Yl)-Methanonone Derivatives and Related Compounds as Insecticides CHRM1, NPY1R, MRM1 ESR2 2588/4885MAPK1 623/4885HPGD 2647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback